Abeona Therapeutics (ABEO) reported a loss of $0.20 per share in its second quarter, missing consensus forecast by 4 cents. The company reported revenue of $0.21 million, down 25% on a year-over-year basis. Revenue missed consensus forecast by $0.03 million.

Immune Pharmaceuticals (IMNP) reported a loss of $0.13 per share in its second quarter. The company ended the quarter with $0.4 million in cash and cash equivalents on its balance sheet.

Protea Biosciences (PRGB) reported a net loss of $1.44 million in second quarter. The company reported revenue of $0.58 million, up 20% on a year-over-year basis.

International Stem Cell (ISCO) reported second-quarter earnings of $0.26 per share. The company reported revenue of $1.92 million, up 5.5% on a year-over-year basis.

XBiotech (XBIT) reported a net loss of $0.42 per share in its second quarter. The company ended the quarter with $64.8 million in cash and cash equivalents on its balance sheet.